The primary objective of this clinical research study is to compare the efficacy and the safety of 3 dose levels of oral TMI-005 in comparison with placebo in subjects with active Rheumatoid Arthritis (RA) who have been receiving stable doses of Methotrexate (MTX).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
390
Unnamed facility
Indianapolis, Indiana, United States
Unnamed facility
Syracuse, New York, United States
Unnamed facility
Duncansville, Pennsylvania, United States
Unnamed facility
West Reading, Pennsylvania, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Montreal, Quebec, Canada
Unnamed facility
Ste-Foy, Quebec, Canada
Unnamed facility
Trois-Rivières, Quebec, Canada
Unnamed facility
Saskatoon, Saskatchewan, Canada